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Elevated levels of homocysteine are associated with several major
diseases. However, it is not clear whether homocysteine is amarker
or a causative agent. The majority (ca. 80%) of the homocysteine
present in humans is protein bound. The study of the posttransla-
tional modification of proteins by homocysteine and its cyclic con-
gener, homocysteine thiolactone, is emerging as an area of great
current interest for unraveling the ongoing “mediator/marker con-
troversy” [Jacobsen DW (2009) Clin Chem 55:1–2]. Interestingly,
many of the pathologies associated with homocysteine are also
linked to oxidative stress. In the current study, chemical evidence
for a causal relationship between homocysteine-bound proteins
and oxidative damage is presented. For example, a reproducible
increase in protein carbonyl functionality occurs as a consequence
of the reaction of human serum albumin with homocysteine
thiolactone. This occurs at physiological temperature upon expo-
sure to air without any added oxidants or free-radical initiators.
Alpha-amino acid carbon-centered radicals, well-known precursors
of protein carbonyls, are shown to form via a hydrogen atom trans-
fer process involving thiolactone-derived homocystamides. Model
peptides in buffer as well as native proteins in human blood
plasma additionally exhibit properties in keeping with the
homocystamide-facilitated hydrogen atom transfer and resultant
carbon-centered radicals.
homocysteine ∣ oxidation ∣ thiyl radicals
Homocysteine (Hcy) is an accepted independent risk factor forseveral major pathologies including cardiovascular disease,
birth defects, osteoporosis, Alzheimer’s disease, and renal failure
(1). Oxidative stress is also linked to declines in pulmonary, brain,
circulatory, and reproductive function. It has been hypothesized
that Hcy promotes oxidative stress via reactive oxygen species
(ROS) generation upon disulfide bond formation. However,
cysteine (Cys) also undergoes disulfide- and ROS-forming reac-
tions, and is more abundant than Hcy, but is not generally asso-
ciated with disease (2). There is thus interest in elucidating the
fundamental chemistry of Hcy that is distinct from that of Cys,
glutathione (GSH), and the other biological thiols. Moreover,
it has been noted that evidence of Hcy-induced protein oxidation
would serve as a significant alternative to measuring its ROS gen-
eration and would link Hcy to oxidative stress-related disorders
(3). Extensive clinical trials, spanning decades and tens of thou-
sands of patients, have not yet established a definitive relation-
ship between Hcy lowering using vitamin therapy and reduced
cardiovascular disease risk. This has resulted in renewed interest
in examining alternative relationships between Hcy and redox
status (4).
There are three main distinctive features of Hcy chemistry.
First, the additional carbon in the Hcy side chain allows it to exist
as a stable five-membered ring thiolactone [homocysteine
thiolactone (HTL)] which readily reacts with the ε-amine of
Lys residues to form isopeptide bonds (Hcy-N-protein, Scheme 1)
as demonstrated by the extensive studies of Jakubowski (3). Sec-
ond, evidence that homocysteine easily forms disulfides with free
thiol groups in proteins was originally reported by Refsum et al.
(5) and further studied by others (6, 7). This was later confirmed
and further studied extensively by the Jacobsen group (1), who
showed that the higher pKa (10.0) of the Hcy sulfhydryl as com-
pared to that of Cys leads to the formation of thermodynamically
stable mixed disulfide bonds to protein Cys residues
(Hcy-S-protein) (1). Third, the Hcy thiyl radical can undergo a
kinetically favored hydrogen atom transfer (HAT) reaction to
afford an alpha-amino carbon-centered radical (Scheme 2). This
latter property of Hcy was first proposed by Zhao et al. (8) and
subsequently shown in our laboratory to occur under neutral
physiological conditions and in human blood plasma (9–11).
Alpha-amino carbon radical formation in Hcy (Scheme 2)
occurs under the same conditions that promote thiyl radical-
mediated disulfide formation (8–11). This is due to the thiyl
radical’s participation in the HAT mechanism. Importantly,
HAT is kinetically favored for Hcy compared to all other bio-
logical thiols due to the five-membered ring transition state
shown in Scheme 2. The αC-H bond of Hcy is weaker than its
S-H bond when the amino group is uncharged (8). Moreover,
we have shown, in collaboration with Crowe and coworkers, that
the HAT process for Hcy still proceeds effectively in mildly acidic
media (12).
This unique property of Hcy has allowed its highly selective
detection in neutral buffer and in human blood plasma using
mildly oxidizing chromogens such as methyl viologen (11–13)
(Ered ¼ −0.448 V) (14). This is because the αC amino acid radical
is a relatively potent reducing agent whereas the thiyl radical is
oxidizing (9). Alpha-amino carbon radical reduction potentials
have been reported as E° ðNH2 ¼ CHRþ∕NH2CHR·Þ ¼
−1.9 V vs. normal hydrogen electrode (15).
Because homocystamide thiyl radicals should also be predis-
posed to a kinetically favored HAT five-membered ring transition
state, we propose that homocystamides can serve as sites promot-
ing free-radical-induced changes to protein structure via αC
amino acid radical formation as depicted in Scheme 3. Herein,
evidence is presented for a mechanism of enhanced protein car-
bon radical formation and oxidation consistent with Hcy’s unique
chemical properties.
Scheme 1. The reaction of HTL with the ε-amine moiety of protein Lys
residues results in a posttranslational modification known as Hcy-N-protein
(7, 13).
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Homocystamides Promote αC Radical Formation in Human Serum Al-
bumin and Directly in Proteins in Human Blood Plasma.To investigate
the effect of protein oxidation due to homocystamide incorpo-
ration, human serum albumin (HSA) was modified with an
average of 7–8 D,L-homocystamides/mol via reaction with
homocysteine thiolactone, following the standard procedures
developed by Jakubowski (7) (SI Appendix). Unbound low mole-
cular weight thiols were removed by gel filtration after disulfide
reduction.
Methyl viologen (as mentioned earlier) has previously been
used as a probe to detect αC radicals during pulse radiolysis
(8, 17) and to detect Hcy with outstanding selectivity due to
the kinetically favored αC radical formation (9–11). It was thus
employed in the current work to help determine that HSA-bound
homocystamides promote αC protein radical formation.
Blue solution color formation due to viologen radical appear-
ance indeed occurs in the presence of homocystamide-enriched
HSA (15 mg∕mL, 2 mM) after 2 min heating at reflux (Fig. 1).
These are conditions similar to those used for detecting carbon
radicals derived from the unbound Hcy molecule (9–11). The
control solution containing (disulfide) reduced, unmodified albu-
min exhibits blue color only after prolonged heating at reflux
(≥twice reaction time). These observations are consistent with
kinetically favored αC formation due to protein homocystamide
enrichment.
A human blood plasma solution treated with HTL similarly
exhibits a blue solution color in the presence of methyl viologen
(2 min, reflux, 15 mg∕mL proteins). Consistent with the results
using isolated HSA in buffer, at least double the reaction time
is needed for color formation to occur in the unmodified sample
solution. In addition, we find that fluorone black, a mildly oxidiz-
ing dye, also previously used to detect free Hcy via alpha
carbon radical formation (9, 10), affords an increase in absor-
bance signal at room temperature in neutral buffer in the pres-
ence of HSA enriched in homocystamides (SI Appendix).
Homocystamides Promote Protein Carbonyl Formation. Cys residue
thiyl radicals can abstract αC-H protons from proximal amino
acid residues of proteins. The ensuing αC radical species react
with oxygen to form superoxide and carbonyls, thereby fragment-
ing peptide backbones (18). In oxygen depleted environments,
radical coupling and related irreversible reactions may occur
as well.
In the case of homocystamide residues, there are fewer
geometric constraints for a hydrogen transfer process to occur
as compared to Cys residues. The homocystamides are not
embedded within the relatively rigid backbone structure and thus
an initial αC-H abstraction can occur via the pathway shown in
Scheme 2. Homocystamides should thus serve as relatively
favored sites for protein free-radical initiation, propagation,
and concomitant structural changes.
To demonstrate that protein oxidation occurs upon homocys-
tamide enrichment, HSA functionalized with 7–8 homocystamide
residues was studied via the standard colorimetric reaction
with 2,4-dinitrophenyl hydrazine (2,4-DNPH). A reproducible
increase (60% for HSA, as well as 24% in an analogous study
using total human plasma proteins; SI Appendix) in the level
of hydrazine-reactive functionality is observed for functionalized
HSA as compared to the corresponding controls consisting of
non-HTL-treated HSA which were subjected to otherwise iden-
tical processing.
Although seemingly modest, this consistent increase in carbon-
yl functionality occurs spontaneously, i.e., during the standard
incubation procedure between HTL and HSA at physiological
temperature, 37 °C, 24 h, without the aid of any added oxidants
or free-radical initiators. Moreover, hydrazine reactivity may
underestimate the structural effects of homocystamide residues
because αC radicals may lead to other by-products undetectable
by 2,4-DNPH (as defined earlier).
Evidence for the Formation of αC Radicals from Homocystamides in
Model Peptide Studies.Amino acid anhydrides, including those de-
rived from alanine (4), glycine, and sarcosine, are well-known
useful model substrates for studying peptide and protein
alpha-amino acid carbon-centered radicals (19).Diketopiperazine
2 was chosen in this investigation to serve as the corre-
sponding Hcy structure analog (we also produce 2 during the
N-homocysteinylation reaction of Lys and Lys residues in vitro,
but find its role in cross-linking proteins is minimal under these
conditions; SI Appendix). We compared the reactions of 1, 2,
Scheme 2. Hcy thiyl radical undergoes a kinetically favored intramolecular
HAT to form a reducing alpha-amino carbon radical. Captodative stabi-
lization of the radical renders the alpha C-H bond weaker than the S-H bond
by ca. 4 Kcal∕mol. The rate constant for the kinetically favored sulfur-to-
carbon-H atom transfer for Hcy is >105 s−1 [at pH 10.5 (8)].
Scheme 3. Kinetically favored HAT process involving Hcy-N-protein should
promote carbonyl formation and multiple fragmentation products including
NH3, H2S, ethylene, and α,β-unsaturated amides, based on direct analogy to
the chemistry of free Hcy. See refs. 9, 10, and references cited therein for the
chemical products resulting from the αC radical of unbound Hcy. Cooper (16)
has also described analogous products upon the enzyme-catalyzed oxidation
of Hcy.
Fig. 1. Solutions heated at reflux for 2 min containing 0.5 M Tris bugger,
pH 7.0, MV2þ (5.2 × 10−2 M). (Upper) (A) MV2þ blank, (B) HTL control solution
treated in the same way as the protein samples, (C) HSA (15 mg∕mL), and (D)
MV2þ and HSA (15 mg∕mL) functionalized with 7–8 homocystamide residues/
mol. (Lower) (E) MV2þ blank, (F) HTL control solution treated in the same way
as the protein samples, (G) plasma control solution, and (H) Hcy-N-protein
enriched plasma.
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The characteristic blue radical cation viologen reduction
product color appears upon heating at reflux (4 min) in neutral
buffer in the presence of 2. Importantly, HPLC product analysis
confirms that 12.9% racemization of meso-2 takes place upon
heating in the presence of MV2þ. The racemization is further
strong evidence for αC radical formation under these conditions.
The corresponding control experiment without added methyl
viologen does not result in any detectable racemization of 2
(SI Appendix). Racemization of N-Hcy-Lys, 3 was not observed
under the achiral stationary phase analysis conditions.
Additionally, a neutral buffer solution of isopeptide 3, a direct
structure analog of Hcy-N-protein (see SI Appendix for full syn-
thesis details), exhibits blue solution color within 4 min, as
above. Solutions containing Hcy-Lys disulfide, reduced GSH,
N-acetyl-HTL, Glu-Cys, or Cys-Gly, each of which cannot under-
go the five-membered ring HAT transition state, do not develop
any color upon heating with methyl viologen for 4 min
(SI Appendix). Relatively harsher conditions (8–10 min at reflux)
are needed for alanine anhydride (1)-methyl viologen solutions to
develop blue color as compared to viologen solutions of 2 and 3.
This is in keeping with the relatively longer reaction times needed
to reduce methyl viologen in the HSA control samples untreated
with HTL.
Each of the results described above is consistent with the hy-
pothesis that the redox and HAT chemistry of Hcy-N-protein is
analogous to that of unbound Hcy molecules. However, methyl
viologen is an unnatural oxidant. In order to further study the
scope of the αC radical forming process, the reactions of 2 with
biological oxidants H2O2, peroxynitrite, and HOCl were studied.
Because H2O2, peroxynitrite, and HOCl exist in the extracellular
matrix and promote Cys residue thiyl radical formation, they are
likely to react with plasma protein homocystamides (20).
We find that the oxidation of 2 in neutral buffer at 37 °C
is dependent on the type of biological oxidant and on the
oxidant∶substrate molar ratio used. In the case of each of the
three oxidants, only one equiv is enough to afford detectable
consumption of 2. At a 2∶oxidant ratio of 1∶1, HOCl and per-
oxynitrite afford approximately the same distribution of products
(SI Appendix) which include mixed disulfides as well as 4
(Scheme 4). HOCl and peroxynitrite are, as expected, stronger
oxidants as compared to H2O2. At 2 and 5 equiv of peroxynitrite
and HOCl, respectively, 4 predominates in the reaction mixtures.
When up to 10 equiv of H2O2 are used, ca. 29% 2 is still present
in the reaction mixture as monitored by HPLC and liquid chro-
matography–mass spectroscopy (LC/MS).
Other relatively polar products, which did not afford detect-
able MS signals to date, as well as mixed disulfides, were observed
in these reactions (SI Appendix). Importantly, compound 4 elutes
as an HPLC peak well resolved from meso and racemic 4 and
exhibits a mass spectrum clearly showing parent ion difference
(loss) of two protons. The formation of 4 from 2 must occur
via the αC radical pathway (Scheme 4).
[4]
The oxidation of isopeptide 3 with hypochlorite, hydrogen
peroxide, and peroxynitrite was also evaluated. Reaction mixture
products were analyzed by LC/MS electrospray ionization
(ESI) in positive mode. The oxidation with hypochlorite and
peroxynitrite consumed compound 3 completely when an equi-
molar amount of oxidant was used and produced a well-resolved
peak with an m∕z (MþHþ) of 262, corresponding to 5
(SI Appendix). Conversely, the reaction with hydrogen peroxide
(5 equiv) did not go to completion. These results are consistent
with those observed for the mechanism of oxidation of 2: the
formation of 5 occurs via the HAT process.
Discussion
In his landmark paper published in 2002, Jakubowski (21) showed
that Hcy is a protein amino acid in humans and that
Hcy-N-protein is a significant component of Hcy metabolism
in humans (21). Values in the literature for levels of N-homocys-
teinylated protein in human plasma determined in healthy indi-
viduals have since been reported by three independent research
groups to date, and are in excellent agreement, ranging from
0.35–0.51 μM (22). Levels correlating with disease reported to
date range from hemodialysis patients exhibiting double the level
of Hcy-N-protein compared to a control group (23) to a 24-30-
fold elevation in Hcy-N-protein in methylenetetrahydrofolate
reductase or cystathionine β-synthase (CBS) deficiency (3).
N-homocysteinylation targets include fibrinogen, low-density
lipoprotein, high-density lipoprotein, albumin, hemoglobin, and
ferritin. Plasma levels of prothromobogenic Hcy-N-fibrinogen
are elevated in human CBS deficiency, which accounts for
Scheme 4. Proposed mechanism for the formation of compound 4 from
diketopiperazine 2.






increased susceptibility to thrombogenesis observed in CBS-
deficient humans. Moreover, an autoimmune response is caused
by Hcy-N-proteins, which has been shown to be clearly associated
with stroke and coronary artery disease (3). Despite this evidence,
Hcy-N-protein pathophysiology has been recently characterized
as unproven (24).
In the current investigation, we have examined homocystamide
chemistry. The aim was to contribute to an understanding of the
chemical role of Hcy-N-protein, particularly in protein oxidation.
Each of the examples investigated, including HSA in buffer,
total plasma proteins in human plasma, cyclic peptides, and
the isopeptide Hcy-N-lysine exhibited evidence of αC radical
formation and concomitant oxidation in the presence of a variety
of oxidants over a range of concentrations. Importantly, HSA
displayed enhanced carbonyl formation at physiological tempera-
ture without added oxidants, simply upon homocystamide
enrichment. The results described herein complement earlier
studies of the properties of Hcy-N-protein, which showed that
homocystamides render proteins more prone to oxidation as
evidenced by enhanced disulfide formation (25, 26) and alteration
of the redox status of cytochrome c (27).
Another natural source of thiyl radicals to consider is the well-
known transition metal-catalyzed oxidation of biological thiols.
For example, 20% of all Hcy in circulation is believed to undergo
autooxidation, i.e., free-radical-mediated disulfide formation, in
a process catalyzed by copper-bound albumin (1). Chemical
evidence presented herein for homocystamides, and previously
for free Hcy (5–7), shows that disulfide formation via auto-
oxidation is accompanied by intramolecular HATchemistry. This
affords highly reactive free Hcy- and Hcy-N-protein-derived αC
radicals under oxidative conditions that can also enhance
Hcy-S-protein formation. The kinetically favored HATchemistry
of Hcy is thus potentially relevant to all forms of Hcy.
Conclusion
Several of the major diseases associated with elevated levels of
homocysteine are also linked to oxidative stress. Elucidation of
the altered redox status of hyperhomocysteinemic patients is
needed as a step toward targeted therapy (4). In this study, strong
evidence is presented showing that an intramolecular HAT
mechanism provides chemical rationale for the sought after
(2) link between protein oxidation and homocysteine.
The kinetically favored formation of αC radicals renders
Hcy-N-protein capable of initiating oxidative damage under the
natural conditions that induce thiyl radical formation. Moreover,
the amount of αC radicals and their resultant products (20) are
expected to reflect the total circulating Hcy (including
homocystamides). This is due to the fact that (i) 20% conversion
of all circulating Hcy undergoes autooxidation (1) and (ii) a large
proportion [e.g., quantitative (28)] of thiyl radicals formed during
autooxidation are well known to afford αC radicals under physio-
logical conditions (8–11). Further studies involving the detection
and unique chemistry of homocysteine and its various naturally oc-
curring bound and unbound forms are ongoing in our laboratory.
Materials and Methods
Fatty free HSA and lyophilized human plasma were obtained from Sigma-
Aldrich. All other reagents were obtained from commercial sources and used
without further purification. Commercially available oxidized BSA was
obtained from Cell Biolabs. Standard PD-10 columns (10 mL of Sephadex
G-25 medium, gravity flow) were obtained from GE Healthcare. UV-visible
(UV-vis) measurements were collected on a UV-Vis Cary 50 instrument
(Varian, Inc.). HPLC was carried out using either a Nova Pak C18 300 Å,
4 μm, 3.9 × 150 mm (Waters, USA) column or a Discovery C18 300 Å, 5 μm,
2.1 × 250 mm (Supelco) on a Waters 1525 binary pump equipped with a
Waters 2996 photodiode array detector. 1H NMR and 13C NMRwere obtained
on an ARX-400 Advance Bruker spectrometer. ESI [low-resolution mass spec-
trometry (LRMS) or high-resolution mass spectrometry (HRMS)] spectra were
obtained at Mass Spectrometry Facility of Georgia State University. LC/MS
analysis of oxidation reaction mixtures were carried out at the Mass Spectro-
metry Facility in Portland State University using a Discovery C18 300 Å, 5 μm,
2.1 × 250 mm (Supelco) and/or Atlantis hyrophilic interaction liquid chroma-
tography silica, 100 Å, 5 μm, 2.1 × 150 mm (Waters, USA) on an Accela LC
system, and a Finnigan LTQ-XL linear ion trap and LTQ Orbitrap discovery
mass spectrometer detectors. More specific procedures are included in
SI Appendix.
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